Clinical Trials Browser

Interventional × Small Cell Lung Carcinoma × pazopanib × Clear all

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Gastrointestinal Neoplasms, Glioblastoma, Hypertension, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Small Cell Lung Carcinoma

NCT01253369 2019-04-23

Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer

Phase 2 Completed

33 enrolled 8 charts

Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT01313663 2014-10-27

A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population

Phase 2 Terminated

20 enrolled 21 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

Clinical Trials

HYPAZ

Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer

A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population